Respiratory

>

Latest News

FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years

May 13th 2024

The federal agency has accepted the sBLA for Priority Review designation, with a target action date of September 15, 2024.

Nirsevimab reservation program enrollment deadline extended | Image Credit: © rarrarorro - © rarrarorro - stock.adobe.com.
Nirsevimab reservation program enrollment deadline extended

May 9th 2024

Highlights of the May 2024 issue of Contemporary Pediatrics
Highlights of the May 2024 issue of Contemporary Pediatrics

May 6th 2024

Nirsevimab reduced RSV hospitalizations in infants by 82%, new data shows | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.
Nirsevimab reduced RSV hospitalizations in infants by 82%, new data show

May 2nd 2024

RSV Hospitalizations Quadrupled Among Young Children After COVID-19
RSV hospitalizations quadrupled among young children after COVID-19

April 18th 2024

Latest CME Events & Activities

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD

View More

Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age

View More

A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology

View More

<1
...
34567
© 2024 MJH Life Sciences

All rights reserved.